Every material Form 8-K Canopy Growth Corp has filed with the SEC since August 07, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Canopy Growth reported fiscal second-quarter 2027 results for the three months ended September 30, 2026, with consolidated net revenue up 22% to C$81.4 million, led by a 141% rise in international cannabis sales. Net loss increased by $35.7 million from the prior-year quarter because of $35.8 million of fair value charges on Canopy USA related assets, and gross margin fell to 29% from 33%. Shareholders get higher sales and a narrower adjusted EBITDA loss, but a larger reported net loss.
Consolidated net revenue was C$81.4 million, up 22%; Cannabis segment revenue was C$66.2 million, up 30%.
International markets cannabis revenue rose 141% to C$12.3 million from C$5.1 million, driven by Germany and Poland.
Net loss rose by $35.7 million, driven by $35.8 million of fair value charges on Canopy USA related assets.
Adjusted EBITDA loss was C$2.9 million, an improvement of C$0.2 million or 6%; Storz & Bickel revenue fell 4% to C$15.1 million.
Canopy Growth received a Nasdaq letter dated October 14, 2026, saying its common shares have traded below $1.00 for 30 consecutive business days. The Letter has no immediate effect on the Nasdaq listing, and the company has until April 12, 2027 to regain compliance, with a possible reverse stock split proposed to shareholders at an October 23, 2026 reconvened meeting.
Nasdaq Letter dated October 14, 2026 cites Listing Rule 5450(a)(1) minimum bid price requirement of $1.00 per share
Compliance period runs 180 calendar days to April 12, 2027; shares must close at or above $1.00 for at least ten consecutive business days
Share Consolidation Proposal would allow a ratio of one new share for every five to 15 old shares, set by the board, before October 23, 2027
Annual Meeting reconvenes Friday, October 23, 2026 after a lack of quorum on September 25, 2026; the company states no assurance of approval or price increase
Canopy Growth's auditor, PKF O'Connor Davies, resigned effective August 7, 2026, citing a strategic change in its desire to serve the cannabis sector. MNP LLP was engaged the same day as the independent registered public accounting firm for the fiscal year ending March 31, 2027. The filing also discloses an adverse internal control opinion and prior restatements, which bear on shareholders' confidence in the company's financial reporting.
PKF O'Connor Davies resigned effective August 7, 2026, citing strategic changes in its desire to provide services to the cannabis sector.
Its June 15, 2026 report on internal control over financial reporting as of March 31, 2026 was adverse, due to a material weakness in classifying equity-linked instruments as equity or liabilities.
The company restated financial statements for fiscal 2024 and 2025 and certain quarters, citing non-cash accounting errors on share-settled U.S. dollar-priced warrants, as disclosed May 15, 2026.
MNP LLP, a Canadian firm, was engaged on August 7, 2026 for the fiscal year ending March 31, 2027.
Canopy Growth reported fiscal first-quarter 2027 results for the three months ended June 30, 2026, with consolidated net revenue up 13% to $81.2 million (in Canadian dollars) and net loss 68% lower than a year earlier. Adjusted EBITDA loss narrowed to $3.2 million, and management said it expects further improvement in the second half of fiscal 2027 as the MTL Cannabis integration is completed, though free cash outflow rose sharply.
Consolidated net revenue of $81.2 million, up 13% from the prior-year quarter; Canada medical cannabis revenue up 22%, Storz & Bickel up 6%
Adjusted gross margin rose to 31% from 25%; consolidated gross margin was 27% versus 25%
Adjusted EBITDA loss of $3.2 million, an improvement of $4.7 million or 59% year over year
Free cash outflow increased to $25.7 million from $11.6 million, mainly due to timing of working capital items
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Canopy Growth Corp filing is on SEC EDGAR ↗. 8-K briefs of other companies →